Document is current

Article History

Received: 10 October 2023

Accepted: 18 December 2023

First Online: 6 February 2024

Declarations

:

: JW has been an honorary speaker for Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and has been a member of the advisory boards of Abbott, Biogen, Boehringer Ingelheim, Lilly, MSD Sharp & Dohme, and Roche Pharma and receives fees as a consultant for Immungenetics and Roboscreen. JW holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945. CB and JS are employees of Microdiscovery GmbH, Berlin, Germany. IL, KW and DO are employees of Roboscreen GmbH, Leipzig, Germany. BM, HWK, HE, OW and NH declare no competing interests.

: The collection and archiving of biological samples and clinical data in strictly pseudonymous form in a local biobank and their use in biomarker research were approved by the ethics committee of the University Goettingen (9/2/16). From all participants or their legal representatives, written informed consent was obtained prior to the inclusion in the biobank. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Not applicable.